References
JE Greenlee HR Brashear (1983) ArticleTitleAntibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma Ann Neurol 14 609–613 Occurrence Handle10.1002/ana.410140603 Occurrence Handle1:STN:280:BiuD2sfjvVY%3D Occurrence Handle6360029
F Graus JY Delattre JC Antoine J Dalmau B Giometto W Grisold J Honnorat PS Smitt Ch Vedeler JJ Verschuuren A Vincent R Voltz (2004) ArticleTitleRecommended diagnostic criteria for paraneoplastic neurological syndromes J Neurol Neurosurg Psychiatry 75 1135–1140 Occurrence Handle10.1136/jnnp.2003.034447 Occurrence Handle1:STN:280:DC%2BD2czlsFGitg%3D%3D Occurrence Handle15258215
ME Sunday N Choi ER Spindel WW Chin EJ Mark (1991) ArticleTitleGastrin-releasing peptide gene expression in small cell and large cell undifferentiated lung carcinomas Hum Pathol 22 1030–1039 Occurrence Handle10.1016/0046-8177(91)90011-D Occurrence Handle1:STN:280:ByyD1cvhsVQ%3D Occurrence Handle1668786
Y Miyake T Kodama K Yamaguchi (1994) ArticleTitlePro-gastrin-releasing peptide (31–98) is a specific tumor marker in patients with small cell lung carcinoma Cancer Res 54 2136–2140 Occurrence Handle1:STN:280:ByuB38fltlc%3D Occurrence Handle8174119
PJ Lamy J Grenier A Kramar JL Pujol (2000) ArticleTitlePro-gastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancer Lung Cancer 29 197–203 Occurrence Handle10.1016/S0169-5002(00)00113-6 Occurrence Handle1:STN:280:DC%2BD3M%2FhsVyjtw%3D%3D Occurrence Handle10996422
J Schneider M Philipp HG Velcovsky H Morr N Katz (2003) ArticleTitlePro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases Anticancer Res 23 885–893 Occurrence Handle1:CAS:528:DC%2BD3sXltlGnsro%3D Occurrence Handle12820318
R Molina JM Auge J Alicarte X Filella N Vinolas AM Ballesta (2004) ArticleTitlePro-gastrin-releasing peptide in patients with benign and malignant diseases Tumour Biol 25 56–61 Occurrence Handle1:CAS:528:DC%2BD2cXksl2nsrg%3D Occurrence Handle15192313
KY Lam CY Lo (2002) ArticleTitleMetastatic tumours of the adrenal glands: a 30-year experience in a teaching hospital Clin Endocrinol (Oxf) 56 95–101 Occurrence Handle10.1046/j.0300-0664.2001.01435.x
GA Kaltsas JJ Mukherjee AB Grossman (2001) ArticleTitleThe value of radiolabelled MIBG and octreotide in the diagnosis and management of neuroendocrine tumours Ann Oncol 12 IssueIDSuppl 2 S47–S50 Occurrence Handle11762352
MJ Kelley KL Becker JM Rushin D Venzon R Phelps DC Ihde DP Bliss SuffixJr K Melby RH Snider BE Johnson (1994) ArticleTitleCalcitonin elevation in small cell lung cancer without ectopic production Am J Respir Crit Care Med 149 183–190 Occurrence Handle1:STN:280:ByuC2MvpslM%3D Occurrence Handle8111580
R Elisei V Bottici F Luchetti G Coscio ParticleDi C Romei L Grasso P Miccoli P Iacconi F Basolo A Pinchera F Pacini (2004) ArticleTitleImpact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders J Clin Endocrinol Metab 89 163–168 Occurrence Handle1:CAS:528:DC%2BD2cXmvFeqsA%3D%3D Occurrence Handle14715844
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Petravić, D., Habek, M., Perković, Z. et al. Subacute Cerebellar Degeneration Associated with Calcitonin Producing Tumor. J Neurooncol 76, 215–217 (2006). https://doi.org/10.1007/s11060-005-4571-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-005-4571-8